VERTEX PHARMACEUTICALS INC / MA (VRTX)

VERTEX PHARMACEUTICALS INC / MA (VRTX) public financial performance, SEC filing summary, and valuation metrics.

Financial highlights

Contract Revenue: -25500000 usd (2026-03-31)
Operating Income: 1138100000 usd (2026-03-31)
Net Income: 1031400000 usd (2026-03-31)
Operating Income: 4173300000 usd (2025-12-31)
Net Income: 3953200000 usd (2025-12-31)
Contract Revenue: -73300000 usd (2025-12-31)
Net Income: 1082900000 usd (2025-09-30)
Contract Revenue: 0 usd (2025-09-30)
Operating Income: 1186200000 usd (2025-09-30)
Net Income: 1032900000 usd (2025-06-30)
Operating Income: 1151100000 usd (2025-06-30)
Contract Revenue: 20700000 usd (2025-06-30)
Operating Income: 630100000 usd (2025-03-31)
Contract Revenue: 10000000 usd (2025-03-31)
Net Income: 646300000 usd (2025-03-31)
Operating Income: -232900000 usd (2024-12-31)
Contract Revenue: 35700000 usd (2024-12-31)
Net Income: -535600000 usd (2024-12-31)
Operating Income: 1116300000 usd (2024-09-30)
Contract Revenue: 2585000000 usd (2024-09-30)